Global Nanomedicine Market 2012-2016

TechNavio's analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market.
TechNavio's report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.
The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC, Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global Nanotechnology Market
Market Overview
06.2 Global Nanomedicine Market
Market Size and Forecast
06.3 Five Forces Analysis
07. Key Market Segmentation
07.1 Segmentation by Application
07.2 Global Nanomedicine Market in Anticancer Applications
Market Size and Forecast
07.3 Global Nanomedicine Market in CNS Applications
Market Size and Forecast
07.4 Global Nanomedicine Market in Anti-infective Application
Market Size and Forecast
07.5 Global Nanomedicine Market in Anti-inflammatory Application
Market Size and Forecast
07.6 Global Nanomedicine Market in Cardiovascular Application
Market Size and Forecast
07.7 Global Nanomedicine Market in Other Applications
Market Size and Forecast
08. Geographical Segmentation
09. Key Leading Countries
USA
Germany
Japan
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
17.2 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
17.3 Bristol-Myers Squibb Co.
Business Overview
Key Information
SWOT Analysis
17.4 Celgene Corp.
Business Overview
Key Information
SWOT Analysis
17.5 GlaxoSmithKline plc
Business Overview
Key Information
SWOT Analysis
17.6 Pfizer Inc.
Business Overview
Key Information
SWOT Analysis
18. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Nanomedicine Market by Application Types
Exhibit 3: Global Nanomedicine Market 2012-2016 (US$ billion)
Exhibit 4: Global Nanomedicine Market by Application Types
Exhibit 5: Global Nanomedicine Market by Application Types 2012 (in percent)
Exhibit 6: Global Nanomedicine Market by Application Types 2012-2016 (in percent)
Exhibit 7: Global Nanomedicine Market in Anticancer Application 2012-2016 (US$ billion)
Exhibit 8: Global Nanomedicine Market in CNS Application 2012-2016 (US$ billion)
Exhibit 9: Global Nanomedicine Market in Anti-infective Applications 2012-2016 (US$ billion)
Exhibit 10: Global Nanomedicine Market in Anti-inflammatory Applications 2012-2016 (US$ billion)
Exhibit 11: Global Nanomedicine Market in Cardiovascular Application 2012-2016 (US$ billion)
Exhibit 12: Global Nanomedicine Market in Other Applications 2012-2016 (US$ billion)
Exhibit 13: Global Nanomedicine Market by Geographical Segmentation 2012
Exhibit 14: Business Segmentation of Abbott Laboratories
Exhibit 15: Business Segmentation of AstraZeneca plc
Exhibit 16: Business Segmentation of Bristol-Myers Squibb Co.
Exhibit 17: Business Segmentation of Celgene Corp.
Exhibit 18: Business Segmentation of GlaxoSmithKline plc
Exhibit 19: Business Segmentation of Pfizer Inc.